A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology

Summary

The investigators are here to invite participants to participate in a medical research project, and this informed consent form provides participants with information to decide whether or not to participate in this study. Please read the following carefully and discuss any questions and terms that are not clear with the study doctor. The participants' participation in this study is completely voluntary and the project has been reviewed by the Research Ethics Committee of Qilu Hospital, Shandong University.

Conditions

• Bladder Cancer

Interventions

OTHER

Organoid culture

Organoid culture of tumor tissue obtained during patient surgery

Sponsors & Collaborators

• The Second Hospital of Shandong University

  collaborator OTHER

• Shandong First Medical University

  collaborator OTHER

• Shandong Provincial Hospital

  collaborator OTHER_GOV

• Shandong Province Third hospital

  collaborator OTHER

• Taian City Central Hospital

  collaborator OTHER

• Weifang People's Hospital

  collaborator OTHER

• Binzhou Medical University

  collaborator OTHER

• The Affiliated Hospital of Qingdao University

  collaborator OTHER

• Jining First People's Hospital

  collaborator OTHER

• Liaocheng People's Hospital

  collaborator OTHER

• Linyi People's Hospital

  collaborator OTHER

• Yantai Yuhuangding Hospital

  collaborator OTHER

• Zibo Central Hospital

  collaborator OTHER_GOV

• Dezhou People's Hospital

  collaborator OTHER

• The Affiliated Hospital of Jining Medical University and Zaozhuang City

  collaborator UNKNOWN

• Qilu Hospital of Shandong University (Qingdao)

  collaborator OTHER

• Qilu Hospital of Shandong University

  lead OTHER

Eligibility

Min Age

18 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-10-01

Primary Completion

2028-09-30

Completion

2028-09-30

Countries

• China

Study Locations